bpc-157 clinical trial recruiting BPC-157: What the Science Actually Says Frontiers | Pharmacokinetics, distribution, metabolism,

TB-500 (Thymosin Beta-4) Phase I and Phase II safety trials of intravenous thymosin beta-4 published in human cohorts (Ruff et al., 2010)

Statements Author contributions AS: Conceptualization, Methodology, Resources, Writing original draft, Writing review & editing

Safe Chain Solutions, LLC, a wholesale drug distributer, received the second warning letter ever issued 18 for DSCSA violations tied to repeated distribution of counterfeit HIV antiviral drugs

Wash your hands thoroughly or wear disposable gloves

Both have a wealth of scientific support for their efficacy, but tirzepatide has a bit more evidence behind it